The Trump administration is facing conflicting political pressures after Health Secretary Robert F. Kennedy Jr. said the Food and Drug Administration will "study" adding safety restrictions on ...

The Food and Drug Administration will review evidence about the safety and efficacy of the abortion drug Mifepristone.

Currently, telehealth accounts for a quarter of abortions in the U.S., and in 2023, nearly two-thirds of abortions were done ...

The Trump administration said it will review the medication abortion drug mifepristone (Mifeprex) to see whether current ...

Wyoming Attorney General Keith Kautz said he joined 21 other states in asking the FDA to investigate an abortion-inducing ...

The US Food and Drug Administration is reviewing evidence about the safety and efficacy of mifepristone, one of the drugs ...

Data analyzed by CNN shows mifepristone — the first drug in the medication abortion process — is even safer than some common, low-risk prescription drugs, including penicillin and Viagra.

HHS and FDA launch review of abortion pill mifepristone after disputed safety study, sparking backlash from abortion rights advocates.

Mifepristone is the primary way abortions continue in states with bans, because it can be prescribed and sent via telehealth.

Health and Human Services Secretary Robert F. Kennedy Jr. has launched a Food and Drug Administration review of mifepristone, a pill used in nearly two-thirds of abortions across the U.S.

Health and Human Services Secretary Robert F. Kennedy Jr. told Republican states this week that the FDA would conduct a new review of abortion pills.

Kennedy Jr. announced this week that the FDA will launch a fresh review of mifepristone, the primary drug used for medication ...